Articles

Dopamine beta-hydroxylase mediates atherosclerosis progression by regulating copper metabolism via PHOX2A

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 27 October 2026
133
Views
101
Downloads

Authors

Atherosclerosis (AS) is a major cardiovascular disease whose underlying molecular mechanisms remain incompletely understood. This study investigates the role of dopamine beta-hydroxylase (DBH) in AS pathogenesis and its regulation of copper metabolism via the transcription factor PHOX2A. Through transcriptomic profiling of aortic tissues from ApoE⁻/⁻ mice fed a high-fat diet, we identified 2891 differentially expressed genes (DEGs) between AS and control mice, with DBH being significantly upregulated. DBH expression was also elevated in the serum of AS patients and in ox-LDL-treated human vascular smooth muscle cells (HVSMCs). Mechanistically, we demonstrate that PHOX2A directly activates the DBH promoter, and that DBH knockdown attenuates ox‑LDL‑induced apoptosis and lipid accumulation in HVSMCs while PHOX2A overexpression exacerbates these effects. Importantly, DBH knockdown in ApoE⁻/⁻ mice not only reduced atherosclerotic plaque burden and improved serum lipid profiles but also restored serum copper concentrations and altered the expression of cuproptosis‑related proteins (FDX1, LIAS, DLAT). These findings identify DBH as a key mediator of AS progression linked to PHOX2A‑dependent regulation of copper metabolism and cuproptosis, suggesting that targeting the DBH/PHOX2A axis may represent a novel therapeutic strategy for AS.

Downloads

Download data is not yet available.

Citations

1. Kobiyama K, Ley K. Atherosclerosis. Circ Res 2018;123:1118-20. DOI: https://doi.org/10.1161/CIRCRESAHA.118.313816
2. Libby P, Buring JE, Badimon L, Hansson GK, Deanfield J, Bittencourt MS, et al. Atherosclerosis. Nat Rev Dis Primers 2019;5:56. DOI: https://doi.org/10.1038/s41572-019-0106-z
3. Herrington W, Lacey B, Sherliker P, Armitage J, Lewington S. Epidemiology of atherosclerosis and the potential to reduce the global burden of atherothrombotic disease. Circ Res 2016;118:535-46. DOI: https://doi.org/10.1161/CIRCRESAHA.115.307611
4. Fan J, Watanabe T. Atherosclerosis: known and unknown. Pathol Int 2022;72:151-60. DOI: https://doi.org/10.1111/pin.13202
5. Jungwirth U, Kowol CR, Keppler BK, Hartinger CG, Berger W, Heffeter P. Anticancer activity of metal complexes: involvement of redox processes. Antioxid Redox Signal 2011;15:1085-27. DOI: https://doi.org/10.1089/ars.2010.3663
6. Gu J, Huang W, Duanmu Z, Zhuang R, Yang X. Cuproptosis and copper deficiency in ischemic vascular injury and repair. Apoptosis 2024;29:1007-18.
7. Zuo X, Ding X, Zhang Y, Kang YJ. Reversal of atherosclerosis by restoration of vascular copper homeostasis. Exp Biol Med (Maywood) 2024;249:10185. DOI: https://doi.org/10.3389/ebm.2024.10185
8. Dong D, Wang B, Yin W, Ding X, Yu J, Kang YJ. Disturbance of copper homeostasis is a mechanism for homocysteine-induced vascular endothelial cell injury. PLoS One 2013;8:e76209. DOI: https://doi.org/10.1371/journal.pone.0076209
9. Yang S, Li Y, Zhou L, Wang X, Liu L, Wu M. Copper homeostasis and cuproptosis in atherosclerosis: metabolism, mechanisms and potential therapeutic strategies. Cell Death Discov 2024;10:25. DOI: https://doi.org/10.1038/s41420-023-01796-1
10. Zhang H, Cotecchia S, Thomas SA, Tanoue A, Tsujimoto G, Faber JE. Gene deletion of dopamine beta-hydroxylase and alpha1-adrenoceptors demonstrates involvement of catecholamines in vascular remodeling. Am J Physiol Heart Circ Physiol 2004;287:H2106-14. DOI: https://doi.org/10.1152/ajpheart.00290.2004
11. Rush RA, Geffen LB. Dopamine beta-hydroxylase in health and disease. Crit Rev Clin Lab Sci 1980;12:241-77. DOI: https://doi.org/10.3109/10408368009108731
12. Schmidt K, Ralle M, Schaffer T, Jayakanthan S, Bari B, Muchenditsi A, Lutsenko S. ATP7A and ATP7B copper transporters have distinct functions in the regulation of neuronal dopamine-β-hydroxylase. J Biol Chem 2018;293:20085-98.
13. Xue Q, Kang R, Klionsky DJ, Tang D, Liu J, Chen X. Copper metabolism in cell death and autophagy. Autophagy 2023;19:2175-95. DOI: https://doi.org/10.1080/15548627.2023.2200554
14. Card JP, Lois J, Sved AF. Distribution and phenotype of Phox2a-containing neurons in the adult sprague-dawley rat. J Comp Neurol 2010;518:2202-20. DOI: https://doi.org/10.1002/cne.22327
15. Kim HS, Seo H, Yang C, Brunet JF, Kim KS. Noradrenergic-specific transcription of the dopamine beta-hydroxylase gene requires synergy of multiple cis-acting elements including at least two Phox2a-binding sites. J Neurosci 1998;18:8247-60. DOI: https://doi.org/10.1523/JNEUROSCI.18-20-08247.1998
16. Qin Y, Liu Y, Xiang X, Long X, Chen Z, Huang X, et al. Cuproptosis correlates with immunosuppressive tumor microenvironment based on pan-cancer multiomics and single-cell sequencing analysis. Mol Cancer 2023;22:59. DOI: https://doi.org/10.1186/s12943-023-01752-8
17. Khatana C, Saini NK, Chakrabarti S, Saini V, Sharma A, Saini RV, Saini AK. Mechanistic insights into the oxidized low-density lipoprotein-induced atherosclerosis. Oxid Med Cell Longev 2020;2020:5245308. DOI: https://doi.org/10.1155/2020/5245308
18. Chen X, Cai Q, Liang R, Zhang D, Liu X, Zhang M, et al. Copper homeostasis and copper-induced cell death in the pathogenesis of cardiovascular disease and therapeutic strategies. Cell Death Dis 2023;14:105. DOI: https://doi.org/10.1038/s41419-023-05639-w
19. Pfeil U, Kuncova J, Brüggmann D, Paddenberg R, Rafiq A, Henrich M, et al. Intrinsic vascular dopamine - a key modulator of hypoxia-induced vasodilatation in splanchnic vessels. J Physiol 2014;592:1745-56. DOI: https://doi.org/10.1113/jphysiol.2013.262626
20. Nagatsu T, Ikuta K, Numata Y, Kato T, Sano M. Vascular and brain dopamine beta-hydroxylase activity in young spontaneously hypertensive rats. Science 1976;191:290-1. DOI: https://doi.org/10.1126/science.1858
21. Schmidt K, Ralle M, Schaffer T, Jayakanthan S, Bari B, Muchenditsi A, Lutsenko S. ATP7A and ATP7B copper transporters have distinct functions in the regulation of neuronal dopamine-β-hydroxylase. J Biol Chem 2018;293:20085-98. DOI: https://doi.org/10.1074/jbc.RA118.004889
22. Fang X, Wang X, Hao M, Zhong G, Gao M, Ma Y, et al. The role of copper homeostasis and cuproptosis in cerebrovascular diseases: A novel therapeutic target. Eur J Pharmacol 2025;1001:177649. DOI: https://doi.org/10.1016/j.ejphar.2025.177649
23. Benfante R, Flora A, Di Lascio S, Cargnin F, Longhi R, Colombo S, et al. Transcription factor PHOX2A regulates the human alpha3 nicotinic receptor subunit gene promoter. J Biol Chem 2007;282:13290-302. DOI: https://doi.org/10.1074/jbc.M608616200
24. Kattoor AJ, Pothineni NVK, Palagiri D, Mehta JL. Oxidative stress in atherosclerosis. Curr Atheroscler Rep 2017;19:42. DOI: https://doi.org/10.1007/s11883-017-0678-6
25. Lv X, Zhao L, Song Y, Chen W, Tuo Q. Deciphering the role of copper homeostasis in atherosclerosis: from molecular mechanisms to therapeutic targets. Int J Mol Sci 2024;25:11462. DOI: https://doi.org/10.3390/ijms252111462
26. Gu J, Huang W, Duanmu Z, Zhuang R, Yang X. Cuproptosis and copper deficiency in ischemic vascular injury and repair. Apoptosis 2024;29:1007-18. DOI: https://doi.org/10.1007/s10495-024-01969-y
27. Li J, Li Y, Shen Q, Zhang Y, Yu Y, Li X, Xiong Y. The Yin and Yang of copper in cardiovascular health and disease. Mol Cell Biochem 2026;481:81-107. DOI: https://doi.org/10.1007/s11010-025-05401-0

Ethics Approval

The ethical approval for this study was granted by the Ethics Committee of The First Affiliated Hospital of Wannan Medical University; written informed consent was obtained from all participants prior to their inclusion in the study., All animal experiments were performed in compliance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals and were approved by the Animal Ethics Committee of Wannan Medical College.

CRediT authorship contribution

Qingquan Xue, conceptualization, methodology, formal analysis, investigation, writing – original draft, writing – review & editing. Guilin Feng, formal analysis. Jiqiong Hu, formal analysis. Fangkuan Li, formal analysis, writing – review & editing. Shusen Tang, conceptualization, methodology, writing – review & editing, supervision.

 

Supporting Agencies

This work was supported by the Key Research Project of Wannan Medical College (Project No. WK2023ZZD15).

Data Availability Statement

The data used to support the findings of this study are available from the corresponding author upon request.

 

How to Cite



1.
Xue Q, Feng G, Hu J, Li F, Tang S. Dopamine beta-hydroxylase mediates atherosclerosis progression by regulating copper metabolism via PHOX2A. Eur J Histochem [Internet]. 2026 Oct. 27 [cited 2026 Nov. 10];70(4). Available from: https://www.ejh.it/ejh/article/view/4586